Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL001094

Drug Information
SynonymsDeforolimus (USAN); AP-23573; D08900; AP 23573; Deforolimus; S1022_Selleck; Ridaforolimus; MK 8669; MK-8669; 42-(Dimethylphosphinate)rapamycin; 572924-54-0; AP23573, MK-8669, Ridaforolimus, Deforolimus    
IndicationMetastatic Soft-Tissue Sarcomas; Metastatic Bone SarcomasPhase III    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
PubChem Compound IDCID 23724531.    
PubChem Substance IDSID 17396180.    
TargetSerine/threonine-protein kinase mTORInhibitor[1]
Ref 1Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 2009 Aug;8(8):627-44. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543